Lucid Diagnostics Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$2.0M
Doctors Paid
4,775
Transactions
8,989
2024 Total
$393,957
Payment Breakdown by Category
Research$1.3M (64.2%)
Consulting$462,154 (22.5%)
Food & Beverage$241,355 (11.8%)
Travel$22,730 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.3M | 180 | 64.2% |
| Consulting Fee | $462,154 | 167 | 22.5% |
| Food and Beverage | $241,355 | 8,594 | 11.8% |
| Travel and Lodging | $22,730 | 21 | 1.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,790 | 27 | 0.4% |
Payments by Type
Research
$1.3M
180 transactions
General
$734,028
8,809 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Multicenter Case-Control Study of the Efficacy of EsoGuardO on Samples Collected Using EsoCheckO, versus Esophagogastroduodenoscopy, for the Diagnosis of Barretts Esophagus with and without Dysplasia, and for Esophageal Adenocarcinoma | $411,603 | 0 | 39 |
| Clinical Utility Study of EsoGurad on Samples Collected using EsoCheck as a Triage for Endoscopy to Identify Barretts Esophagus | $299,970 | 0 | 16 |
| Analysis andCell sampleCollection- aRetrospective analysis of the clinicalUtility of theEsoCheck device andEsoGuard analysis | $221,226 | 0 | 3 |
| BE2 | $170,917 | 0 | 18 |
| Identifying Individuals at Risk for Barretts Esophagus in a Large Health System Using a Validated Screening Model | $100,000 | 0 | 2 |
| A Multicenter, Single-Arm Study of the Efficacy of EsoGuard on Samples Collected Using EsoCheck versus Esophagogastroduodenoscopy for the Diagnosis of Barretts Esophagus in an At-Risk Screening Population | $60,810 | 0 | 18 |
| Clinical Utility of a Non endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barretts Esophagus in At Risk Population (ASBE) A Randomized Controlled, Virtual Patient Trial | $31,500 | 63 | 63 |
| BE1 | $10,205 | 0 | 2 |
| Clinical Utility of a Non endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barretts Esophagus in At Risk Population (ASBE) A Randomized Controlled | $9,500 | 19 | 19 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2021 |
|---|---|---|---|---|
| Kristle Lynch | Internal Medicine | Philadelphia, PA | $1,000 | $0 |
| Joy Chang, M.d, M.D | Internal Medicine | Ann Arbor, MI | $1,000 | $0 |
| Kathryn Peterson, Md, MD | Gastroenterology | Salt Lake City, UT | $1,000 | $0 |
| Jeffrey Alexander, M.d, M.D | Gastroenterology | Rochester, MN | $1,000 | $0 |
| Claire Beveridge, Md, MD | Gastroenterology | Cleveland, OH | $1,000 | $0 |
| Gary Falk, Md, MD | Gastroenterology | Philadelphia, PA | $1,000 | $0 |
| Dr. Dipali Patel | Family Medicine | Tampa, FL | $924.58 | $0 |
| Troy Sterk, D.o, D.O | Emergency Medicine | Tampa, FL | $876.26 | $0 |
| Craig Zalvan, Md, MD | Otolaryngology | Tarrytown, NY | $805.08 | $0 |
| Dr. Bhavtosh Dedania, M.d, M.D | Gastroenterology | Brandon, FL | $786.02 | $0 |
| Catherine Nguyen-Ward, Do, DO | Family Medicine | Las Vegas, NV | $777.73 | $0 |
| Dr. Amy Ghaibeh, Md, MD | Internal Medicine | Denver, CO | $770.40 | $0 |
| Mehrdad Ferdowsian, Do, DO | Emergency Medicine | Henderson, NV | $769.57 | $0 |
| Esther Kim, Do, DO | Family Medicine | Las Vegas, NV | $761.28 | $0 |
| Dr. George Cheeseman, Md, MD | Family Medicine | Riverview, FL | $713.80 | $0 |
| Yassmeen Abdel-Aty, M.d, M.D | Otolaryngology | Tampa, FL | $707.72 | $0 |
| Michelle Lin, Do, DO | Family Medicine | Las Vegas, NV | $698.73 | $0 |
| Baoan Le, M.d, M.D | Family Medicine | Phoenix, AZ | $697.54 | $0 |
| Mrs. Nichola Warnecke, Cnp, CNP | Nurse Practitioner | Lima, OH | $696.96 | $0 |
| Dr. Jacqui Dawson, D.o, D.O | Family Medicine | Riverview, FL | $681.24 | $0 |
| Ricardo Cruz, D.o, D.O | Family Medicine | Las Vegas, NV | $642.46 | $0 |
| Melissa Smith, Aprn, APRN | Nurse Practitioner | Riverview, FL | $627.33 | $0 |
| Gaurav Ghosh, M.d, M.D | Gastroenterology | New York, NY | $624.99 | $0 |
| Megan Strauer, Aprn, Fnp-C, APRN, FNP-C | Family | Kalida, OH | $622.97 | $0 |
| Dr. Jacob Moremen, M.d, M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Jackson, MS | $620.74 | $0 |
Ad
Top Products
- ESOCHECK CCD CELL COLLECTION DEVICE $91,584
Associated Products (1)
Payment Categories
- Food & Beverage $241,355
- Consulting $462,154
- Travel & Lodging $22,730
- Research $1.3M
About Lucid Diagnostics Inc.
Lucid Diagnostics Inc. has made $2.0M in payments to 4,775 healthcare providers, recorded across 8,989 transactions in the CMS Open Payments database. In 2024, the company paid $393,957. The top product by payment volume is ESOCHECK CCD CELL COLLECTION DEVICE ($91,584).
Payments were distributed across 118 medical specialties. The top specialty by payment amount is Gastroenterology ($292,987 to 432 doctors).
Payment categories include: Food & Beverage ($241,355), Consulting ($462,154), Research ($1.3M), Travel & Lodging ($22,730).
Lucid Diagnostics Inc. is associated with 1 products in the CMS Open Payments database.